MapLight Therapeutics Inc.

MPLT | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.90

-$0.02 (-0.18%)

At close: Sep 21, 2026, 4:00 PM ET

$11.20

+$0.30 (+2.75%)

After-hours: Sep 21, 2026, 6:22 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.18%

(1D)

Rating

Updated: Sep 19, 2026

23.2

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $462.56M

1D Range

10.78 11.27

52W Range

9.10 40.43

Valuation (TTM)

PE -2.10

PB 1.33

EV/EBITDA -0.69

Valuation (NTM)

Forward PE N/A

Forward PEG 0.10

Price Target $29.20

Cash Flow

FCF Yield -37.9%

SBC Adj. FCF Yield -37.9%

SBC Impact -0.1%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -50.7% | N/A

FCF 3Y | 5Y -47.7% | N/A

Returns

ROA -62.4%

ROE -63.8%

ROIC -69.3%

Financial Health

Net Cash

$303.49M

Current Ratio 16.52

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its p...

Sector Healthcare

Industry Biotechnology

Employees 133

IPO Date Oct 23, 2025

Website www.maplightrx.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$28

Upside

+156.88%

Buy (5)

Hold (1)

Sell (0)

Analyst Details ➞